Nothing Special   »   [go: up one dir, main page]

EP1005360A4 - ANTIOXIDANCE PROTEIN 2, GENES AND METHOD FOR USE THEREOF - Google Patents

ANTIOXIDANCE PROTEIN 2, GENES AND METHOD FOR USE THEREOF

Info

Publication number
EP1005360A4
EP1005360A4 EP98919730A EP98919730A EP1005360A4 EP 1005360 A4 EP1005360 A4 EP 1005360A4 EP 98919730 A EP98919730 A EP 98919730A EP 98919730 A EP98919730 A EP 98919730A EP 1005360 A4 EP1005360 A4 EP 1005360A4
Authority
EP
European Patent Office
Prior art keywords
antioxidance
genes
protein
antioxidance protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98919730A
Other languages
German (de)
French (fr)
Other versions
EP1005360A1 (en
Inventor
Beverly Paigen
David R Beier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Jackson Laboratory
Original Assignee
Brigham and Womens Hospital Inc
Jackson Laboratory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc, Jackson Laboratory filed Critical Brigham and Womens Hospital Inc
Publication of EP1005360A1 publication Critical patent/EP1005360A1/en
Publication of EP1005360A4 publication Critical patent/EP1005360A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP98919730A 1997-04-02 1998-04-01 ANTIOXIDANCE PROTEIN 2, GENES AND METHOD FOR USE THEREOF Withdrawn EP1005360A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4089797P 1997-04-02 1997-04-02
US40897P 1997-04-02
PCT/US1998/006666 WO1998043666A1 (en) 1997-04-02 1998-04-01 Antioxidant protein 2, gene and methods of use therefor

Publications (2)

Publication Number Publication Date
EP1005360A1 EP1005360A1 (en) 2000-06-07
EP1005360A4 true EP1005360A4 (en) 2001-02-07

Family

ID=21913589

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98919730A Withdrawn EP1005360A4 (en) 1997-04-02 1998-04-01 ANTIOXIDANCE PROTEIN 2, GENES AND METHOD FOR USE THEREOF

Country Status (4)

Country Link
EP (1) EP1005360A4 (en)
JP (1) JP2001522229A (en)
CA (1) CA2285631A1 (en)
WO (1) WO1998043666A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2798672B1 (en) * 1999-09-17 2003-10-31 Commissariat Energie Atomique ACIDIC FORMS OF PEROXYREDOXINS AND THEIR USE AS A DIAGNOSIS MEANS
AUPR221300A0 (en) 2000-12-20 2001-01-25 Malaysian Palm Oil Board A molecular marker
EP1566182A4 (en) * 2002-11-10 2009-08-19 Inst Of Cell Biophysics Russia Antioxidant pharmaceutical compound, method for producing polypeptide and method of cure
WO2012075911A1 (en) * 2010-12-06 2012-06-14 Li Jianyuan Use of recombinant human prx-6 protein in treatment of burn and scald and/or corneal injury

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005780A1 (en) * 1990-10-01 1992-04-16 Brigham And Women's Hospital Beta-carotene and vitamin e therapy for inhibition of major vascular events

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992005780A1 (en) * 1990-10-01 1992-04-16 Brigham And Women's Hospital Beta-carotene and vitamin e therapy for inhibition of major vascular events

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9843666A1 *

Also Published As

Publication number Publication date
JP2001522229A (en) 2001-11-13
EP1005360A1 (en) 2000-06-07
CA2285631A1 (en) 1998-10-08
WO1998043666A1 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
DE59706552D1 (en) Projectile and method for its manufacture
DE69737053D1 (en) Chip resistor and method for its manufacture
DE69834015D1 (en) Underwater booster and method for its use
DE69823980D1 (en) LEATHER-LIKE MATERIAL AND METHOD FOR THE PRODUCTION THEREOF
DE59607225D1 (en) SCISSOR-SHAPED, SURGICAL TOOL AND METHOD FOR THE PRODUCTION THEREOF
ATE379971T1 (en) DISINFECTANT AND METHOD FOR THE PRODUCTION THEREOF
DE69820642D1 (en) PROPYLENE COPOLYMERS AND METHOD FOR THE PRODUCTION THEREOF
DE69723453D1 (en) USER-ACTIVATED IONTOPHORETIC DEVICE AND METHOD FOR PREPARING IT
DE69807415D1 (en) Connected metallic component and method and device for its production
DE69801010D1 (en) Prosthetic restoration part and process for its production
DE69603829D1 (en) SCARF CONVERTER AND METHOD FOR THE PRODUCTION THEREOF
DE69703993D1 (en) Iron-in interlining and process for its manufacture
DE69602217D1 (en) Electrically controlled expansion valve and method for its manufacture
DE69502301D1 (en) Loading system and method for its manufacture
DE69739222D1 (en) CAPSULE TONER AND METHOD FOR THE PRODUCTION THEREOF
DE69905326D1 (en) Sollschlitz and method for its production
ATA75297A (en) DECORAMINATE AND METHOD FOR THE PRODUCTION THEREOF
DE69839353D1 (en) STEEL WIRE AND METHOD FOR THE PRODUCTION THEREOF
DE59805833D1 (en) COATING AGENTS AND METHOD FOR THE PRODUCTION THEREOF
DE69813008D1 (en) TIRES AND METHOD FOR THE PRODUCTION THEREOF
DE69800040D1 (en) Gas-tight body and method for its production
DE69634530D1 (en) ANTIVIRAL AGENT AND METHOD FOR THE PRODUCTION THEREOF
DE59805128D1 (en) HEATING ELEMENT AND METHOD FOR THE PRODUCTION THEREOF
DE69827599D1 (en) SHOE AND METHOD FOR THE PRODUCTION THEREOF
DE59607304D1 (en) Curved connector and method of making the same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991101

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 38/43 A, 7A 61K 39/395 B, 7A 61K 48/00 B, 7C 12N 15/11 B, 7C 12N 9/00 B, 7C 12N 15/63 B, 7C 12Q 1/68 B, 7C 12P 19/34 B, 7G 01N 33/53 B, 7C 12N 9/20 B

A4 Supplementary search report drawn up and despatched

Effective date: 20001229

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.

Owner name: THE JACKSON LABORATORY

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041103